Presence of a new BCR-ABL kinase domain mutation, C330G in an imatinib naïve patient with chronic myeloid leukemia: very low prevalence of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from eastern India

Nivedita Kuila Institute of Life Sciences, Department of Gene Regulation and Function, Bhubaneswar, Orissa, India

Nilima Dash Institute of Life Sciences, Department of Gene Regulation and Function, Bhubaneswar, Orissa, India

Devi Prasad Sahoo Sparsh Hospital and Critical Care, Bhubaneswar, Orissa, India

Naresh Chandra Pattnayak Department of Clinical Haematology, SCB Medical College, Cuttack, Orissa, India

Ghanashyam Biswas Sparsh Hospital and Critical Care, Bhubaneswar, Orissa, India

Soumen Chakraborty Institute of Life Sciences, Department of Gene Regulation and Function, Bhubaneswar, Orissa, IndiaCorrespondence[email protected] [email protected]

Click to increase image sizeClick to decrease image size

Notes

There is an accompanying commentary that discusses this paper. Please refer to the issue Table of Contents.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Presence of a new BCR-ABL kinase domain mutation, C330G in an imatinib naïve patient with chronic myeloid leukemia: very low prevalence of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from eastern India

Information for

Open access

Opportunities

Help and information

Presence of a new BCR-ABL kinase domain mutation, C330G in an imatinib naïve patient with chronic myeloid leukemia: very low prevalence of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from eastern India

Notes

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature